#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction to Tissue Engineering Scaffolds and Bottom-Up Fabrication
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract[1]	new[1]	_	_
1-3	16-18	to	abstract[1]	new[1]	_	_
1-4	19-25	Tissue	abstract[1]|object|abstract[3]|abstract[4]	new[1]|new|new[3]|new[4]	coref|coref	3-17|8-1[74_3]
1-5	26-37	Engineering	abstract[1]|abstract[3]|abstract[4]	new[1]|new[3]|new[4]	_	_
1-6	38-47	Scaffolds	abstract[1]|abstract[4]	new[1]|new[4]	_	_
1-7	48-51	and	abstract[1]	new[1]	_	_
1-8	52-61	Bottom-Up	abstract[1]|abstract|abstract[6]	new[1]|new|new[6]	coref	12-4[0_6]
1-9	62-73	Fabrication	abstract[1]|abstract[6]	new[1]|new[6]	_	_

#Text=Traumas , diseases and population ageing are major reasons for damage and failure of human body tissues and organs , which require medical treatments for their restoration or replacement .
2-1	74-81	Traumas	abstract	new	_	_
2-2	82-83	,	_	_	_	_
2-3	84-92	diseases	abstract	new	_	_
2-4	93-96	and	_	_	_	_
2-5	97-107	population	abstract|abstract[10]	new|new[10]	coref	2-8[11_10]
2-6	108-114	ageing	abstract[10]	new[10]	_	_
2-7	115-118	are	_	_	_	_
2-8	119-124	major	abstract[11]	giv[11]	coref	7-2[65_11]
2-9	125-132	reasons	abstract[11]	giv[11]	_	_
2-10	133-136	for	abstract[11]	giv[11]	_	_
2-11	137-143	damage	abstract[11]|abstract	giv[11]|new	_	_
2-12	144-147	and	abstract[11]	giv[11]	_	_
2-13	148-155	failure	abstract[11]|event[13]	giv[11]|new[13]	_	_
2-14	156-158	of	abstract[11]|event[13]	giv[11]|new[13]	_	_
2-15	159-164	human	abstract[11]|event[13]|object[15]|object[16]	giv[11]|new[13]|new[15]|new[16]	coref|coref	6-33[64_15]|7-11[69_16]
2-16	165-169	body	abstract[11]|event[13]|object|object[15]|object[16]	giv[11]|new[13]|new|new[15]|new[16]	coref	3-4
2-17	170-177	tissues	abstract[11]|event[13]|object[15]|object[16]	giv[11]|new[13]|new[15]|new[16]	_	_
2-18	178-181	and	abstract[11]|event[13]|object[16]	giv[11]|new[13]|new[16]	_	_
2-19	182-188	organs	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	ana	2-26[0_17]
2-20	189-190	,	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	_	_
2-21	191-196	which	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	_	_
2-22	197-204	require	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	_	_
2-23	205-212	medical	abstract[11]|event[13]|object[16]|object[17]|abstract[18]	giv[11]|new[13]|new[16]|new[17]|new[18]	_	_
2-24	213-223	treatments	abstract[11]|event[13]|object[16]|object[17]|abstract[18]	giv[11]|new[13]|new[16]|new[17]|new[18]	_	_
2-25	224-227	for	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	_	_
2-26	228-233	their	abstract[11]|event[13]|object[16]|object[17]|object|event[20]	giv[11]|new[13]|new[16]|new[17]|giv|new[20]	coref	7-13
2-27	234-245	restoration	abstract[11]|event[13]|object[16]|object[17]|event[20]	giv[11]|new[13]|new[16]|new[17]|new[20]	_	_
2-28	246-248	or	abstract[11]|event[13]|object[16]|object[17]	giv[11]|new[13]|new[16]|new[17]	_	_
2-29	249-260	replacement	abstract[11]|event[13]|object[16]|object[17]|abstract	giv[11]|new[13]|new[16]|new[17]|new	_	_
2-30	261-262	.	_	_	_	_

#Text=Despite the intrinsic body capability of repairing small injuries given sufficient time , to date , tissue growth in large ( centimeter-size ) defects requires complex , expensive and patient-painful autografts , allografts or xenografts .
3-1	263-270	Despite	_	_	_	_
3-2	271-274	the	abstract[23]	new[23]	_	_
3-3	275-284	intrinsic	abstract[23]	new[23]	_	_
3-4	285-289	body	object|abstract[23]	giv|new[23]	coref	10-9[91_0]
3-5	290-300	capability	abstract[23]	new[23]	_	_
3-6	301-303	of	abstract[23]	new[23]	_	_
3-7	304-313	repairing	abstract[23]	new[23]	_	_
3-8	314-319	small	abstract[23]|event[24]	new[23]|new[24]	_	_
3-9	320-328	injuries	abstract[23]|event[24]	new[23]|new[24]	_	_
3-10	329-334	given	_	_	_	_
3-11	335-345	sufficient	time[25]	new[25]	coref	6-22[62_25]
3-12	346-350	time	time[25]	new[25]	_	_
3-13	351-352	,	_	_	_	_
3-14	353-355	to	_	_	_	_
3-15	356-360	date	time	new	_	_
3-16	361-362	,	_	_	_	_
3-17	363-369	tissue	object|abstract[28]	giv|new[28]	coref|coref	6-17[60_0]|10-28[0_28]
3-18	370-376	growth	abstract[28]	new[28]	_	_
3-19	377-379	in	abstract[28]	new[28]	_	_
3-20	380-385	large	abstract[28]|abstract[30]	new[28]|new[30]	_	_
3-21	386-387	(	abstract[28]|abstract[30]	new[28]|new[30]	_	_
3-22	388-403	centimeter-size	abstract[28]|event|abstract[30]	new[28]|new|new[30]	_	_
3-23	404-405	)	abstract[28]|abstract[30]	new[28]|new[30]	_	_
3-24	406-413	defects	abstract[28]|abstract[30]	new[28]|new[30]	_	_
3-25	414-422	requires	_	_	_	_
3-26	423-430	complex	object[31]	new[31]	_	_
3-27	431-432	,	object[31]	new[31]	_	_
3-28	433-442	expensive	object[31]	new[31]	_	_
3-29	443-446	and	object[31]	new[31]	_	_
3-30	447-462	patient-painful	object[31]	new[31]	_	_
3-31	463-473	autografts	object[31]	new[31]	_	_
3-32	474-475	,	_	_	_	_
3-33	476-486	allografts	object	new	_	_
3-34	487-489	or	_	_	_	_
3-35	490-500	xenografts	object	new	_	_
3-36	501-502	.	_	_	_	_

#Text=In the case of bone , autograft and allograft implantation produces the best clinical results , but it requires secondary surgery and has a limited supply .
4-1	503-505	In	_	_	_	_
4-2	506-509	the	abstract[34]	new[34]	_	_
4-3	510-514	case	abstract[34]	new[34]	_	_
4-4	515-517	of	abstract[34]	new[34]	_	_
4-5	518-522	bone	abstract[34]|object	new[34]|new	_	_
4-6	523-524	,	_	_	_	_
4-7	525-534	autograft	object|event[38]	new|new[38]	ana	4-18[0_38]
4-8	535-538	and	event[38]	new[38]	_	_
4-9	539-548	allograft	object|event[38]	new|new[38]	_	_
4-10	549-561	implantation	event[38]	new[38]	_	_
4-11	562-570	produces	_	_	_	_
4-12	571-574	the	abstract[39]	new[39]	coref	5-19[51_39]
4-13	575-579	best	abstract[39]	new[39]	_	_
4-14	580-588	clinical	abstract[39]	new[39]	_	_
4-15	589-596	results	abstract[39]	new[39]	_	_
4-16	597-598	,	_	_	_	_
4-17	599-602	but	_	_	_	_
4-18	603-605	it	event	giv	coref	5-20
4-19	606-614	requires	_	_	_	_
4-20	615-624	secondary	event[41]	new[41]	coref	5-15[49_41]
4-21	625-632	surgery	event[41]	new[41]	_	_
4-22	633-636	and	_	_	_	_
4-23	637-640	has	_	_	_	_
4-24	641-642	a	abstract[42]	new[42]	_	_
4-25	643-650	limited	abstract[42]	new[42]	_	_
4-26	651-657	supply	abstract[42]	new[42]	_	_
4-27	658-659	.	_	_	_	_

#Text=The main advantage of a xenograft is its abundant supply and no need for secondary surgery , but poor implantation results and problems of infection from donors are critical issues .
5-1	660-663	The	abstract[43]	new[43]	coref	5-8[46_43]
5-2	664-668	main	abstract[43]	new[43]	_	_
5-3	669-678	advantage	abstract[43]	new[43]	_	_
5-4	679-681	of	abstract[43]	new[43]	_	_
5-5	682-683	a	abstract[43]|abstract[44]	new[43]|new[44]	ana	5-8[0_44]
5-6	684-693	xenograft	abstract[43]|abstract[44]	new[43]|new[44]	_	_
5-7	694-696	is	_	_	_	_
5-8	697-700	its	abstract|abstract[46]|abstract[47]	giv|giv[46]|giv[47]	coref	5-8[47_46]
5-9	701-709	abundant	abstract[46]|abstract[47]	giv[46]|giv[47]	_	_
5-10	710-716	supply	abstract[46]|abstract[47]	giv[46]|giv[47]	_	_
5-11	717-720	and	abstract[47]	giv[47]	_	_
5-12	721-723	no	abstract[47]|abstract[48]	giv[47]|new[48]	coref	19-26[189_48]
5-13	724-728	need	abstract[47]|abstract[48]	giv[47]|new[48]	_	_
5-14	729-732	for	abstract[47]|abstract[48]	giv[47]|new[48]	_	_
5-15	733-742	secondary	abstract[47]|abstract[48]|event[49]	giv[47]|new[48]|giv[49]	_	_
5-16	743-750	surgery	abstract[47]|abstract[48]|event[49]	giv[47]|new[48]|giv[49]	_	_
5-17	751-752	,	abstract[47]	giv[47]	_	_
5-18	753-756	but	abstract[47]	giv[47]	_	_
5-19	757-761	poor	abstract[47]|abstract[51]|abstract[52]	giv[47]|giv[51]|giv[52]	coref	5-19[52_51]
5-20	762-774	implantation	abstract[47]|event|abstract[51]|abstract[52]	giv[47]|giv|giv[51]|giv[52]	_	_
5-21	775-782	results	abstract[47]|abstract[51]|abstract[52]	giv[47]|giv[51]|giv[52]	_	_
5-22	783-786	and	abstract[47]|abstract[52]	giv[47]|giv[52]	_	_
5-23	787-795	problems	abstract[47]|abstract[52]|abstract[53]	giv[47]|giv[52]|new[53]	coref	5-29[56_53]
5-24	796-798	of	abstract[47]|abstract[52]|abstract[53]	giv[47]|giv[52]|new[53]	_	_
5-25	799-808	infection	abstract[47]|abstract[52]|abstract[53]|event	giv[47]|giv[52]|new[53]|new	_	_
5-26	809-813	from	abstract[47]|abstract[52]|abstract[53]	giv[47]|giv[52]|new[53]	_	_
5-27	814-820	donors	abstract[47]|abstract[52]|abstract[53]|person	giv[47]|giv[52]|new[53]|new	_	_
5-28	821-824	are	abstract[47]	giv[47]	_	_
5-29	825-833	critical	abstract[47]|abstract[56]	giv[47]|giv[56]	_	_
5-30	834-840	issues	abstract[47]|abstract[56]	giv[47]|giv[56]	_	_
5-31	841-842	.	_	_	_	_

#Text=Besides , the neo-tissue generated within the interstitial spaces of these grafts is often different from the native tissue and requires large remodeling time for the complete biological and biomechanical integration with surrounding tissues .
6-1	843-850	Besides	_	_	_	_
6-2	851-852	,	_	_	_	_
6-3	853-856	the	substance[57]	new[57]	_	_
6-4	857-867	neo-tissue	substance[57]	new[57]	_	_
6-5	868-877	generated	substance[57]	new[57]	_	_
6-6	878-884	within	substance[57]	new[57]	_	_
6-7	885-888	the	substance[57]|place[58]	new[57]|new[58]	_	_
6-8	889-901	interstitial	substance[57]|place[58]	new[57]|new[58]	_	_
6-9	902-908	spaces	substance[57]|place[58]	new[57]|new[58]	_	_
6-10	909-911	of	substance[57]|place[58]	new[57]|new[58]	_	_
6-11	912-917	these	substance[57]|place[58]|object[59]	new[57]|new[58]|new[59]	_	_
6-12	918-924	grafts	substance[57]|place[58]|object[59]	new[57]|new[58]|new[59]	_	_
6-13	925-927	is	_	_	_	_
6-14	928-933	often	_	_	_	_
6-15	934-943	different	_	_	_	_
6-16	944-948	from	_	_	_	_
6-17	949-952	the	object[60]	giv[60]	coref	8-1[0_60]
6-18	953-959	native	object[60]	giv[60]	_	_
6-19	960-966	tissue	object[60]	giv[60]	_	_
6-20	967-970	and	_	_	_	_
6-21	971-979	requires	_	_	_	_
6-22	980-985	large	time[62]	giv[62]	_	_
6-23	986-996	remodeling	abstract|time[62]	new|giv[62]	_	_
6-24	997-1001	time	time[62]	giv[62]	_	_
6-25	1002-1005	for	_	_	_	_
6-26	1006-1009	the	event[63]	new[63]	coref	11-25[107_63]
6-27	1010-1018	complete	event[63]	new[63]	_	_
6-28	1019-1029	biological	event[63]	new[63]	_	_
6-29	1030-1033	and	event[63]	new[63]	_	_
6-30	1034-1047	biomechanical	event[63]	new[63]	_	_
6-31	1048-1059	integration	event[63]	new[63]	_	_
6-32	1060-1064	with	event[63]	new[63]	_	_
6-33	1065-1076	surrounding	event[63]|object[64]	new[63]|giv[64]	coref	7-11[0_64]
6-34	1077-1084	tissues	event[63]|object[64]	new[63]|giv[64]	_	_
6-35	1085-1086	.	_	_	_	_

#Text=For these reasons , the development of novel solutions for tissues and organs bioengineering is extremely demanding in the medical field .
7-1	1087-1090	For	_	_	_	_
7-2	1091-1096	these	abstract[65]	giv[65]	_	_
7-3	1097-1104	reasons	abstract[65]	giv[65]	_	_
7-4	1105-1106	,	_	_	_	_
7-5	1107-1110	the	event[66]	new[66]	_	_
7-6	1111-1122	development	event[66]	new[66]	_	_
7-7	1123-1125	of	event[66]	new[66]	_	_
7-8	1126-1131	novel	event[66]|substance[67]	new[66]|new[67]	_	_
7-9	1132-1141	solutions	event[66]|substance[67]	new[66]|new[67]	_	_
7-10	1142-1145	for	event[66]|substance[67]	new[66]|new[67]	_	_
7-11	1146-1153	tissues	event[66]|substance[67]|object|object[69]|abstract[71]	new[66]|new[67]|giv|giv[69]|new[71]	_	_
7-12	1154-1157	and	event[66]|substance[67]|object[69]|abstract[71]	new[66]|new[67]|giv[69]|new[71]	_	_
7-13	1158-1164	organs	event[66]|substance[67]|object[69]|object|abstract[71]	new[66]|new[67]|giv[69]|giv|new[71]	coref	8-38
7-14	1165-1179	bioengineering	event[66]|substance[67]|abstract[71]	new[66]|new[67]|new[71]	_	_
7-15	1180-1182	is	_	_	_	_
7-16	1183-1192	extremely	_	_	_	_
7-17	1193-1202	demanding	_	_	_	_
7-18	1203-1205	in	_	_	_	_
7-19	1206-1209	the	abstract[72]	new[72]	_	_
7-20	1210-1217	medical	abstract[72]	new[72]	_	_
7-21	1218-1223	field	abstract[72]	new[72]	_	_
7-22	1224-1225	.	_	_	_	_

#Text=Tissue engineering ( TE ) , an important biomedical engineering field , aims to solve this important challenge by combining scaffolds and bioactive molecules for the artificial reconstruction of functional , three-dimensional ( 3D ) tissues and organs .
8-1	1226-1232	Tissue	object|abstract[74]	giv|giv[74]	appos|coref	8-4[0_74]|9-15
8-2	1233-1244	engineering	abstract[74]	giv[74]	_	_
8-3	1245-1246	(	_	_	_	_
8-4	1247-1249	TE	abstract	giv	coref	8-9[76_0]
8-5	1250-1251	)	_	_	_	_
8-6	1252-1253	,	_	_	_	_
8-7	1254-1256	an	abstract[77]	giv[77]	appos|coref	8-7[77_76]|21-23[220_77]
8-8	1257-1266	important	abstract[77]	giv[77]	_	_
8-9	1267-1277	biomedical	abstract[76]|abstract[77]	giv[76]|giv[77]	_	_
8-10	1278-1289	engineering	abstract[76]|abstract[77]	giv[76]|giv[77]	_	_
8-11	1290-1295	field	abstract[77]	giv[77]	_	_
8-12	1296-1297	,	_	_	_	_
8-13	1298-1302	aims	_	_	_	_
8-14	1303-1305	to	_	_	_	_
8-15	1306-1311	solve	_	_	_	_
8-16	1312-1316	this	abstract[78]	new[78]	_	_
8-17	1317-1326	important	abstract[78]	new[78]	_	_
8-18	1327-1336	challenge	abstract[78]	new[78]	_	_
8-19	1337-1339	by	_	_	_	_
8-20	1340-1349	combining	_	_	_	_
8-21	1350-1359	scaffolds	abstract	new	coref	9-1[85_0]
8-22	1360-1363	and	_	_	_	_
8-23	1364-1373	bioactive	object[80]	new[80]	coref	10-21[96_80]
8-24	1374-1383	molecules	object[80]	new[80]	_	_
8-25	1384-1387	for	_	_	_	_
8-26	1388-1391	the	place[81]	new[81]	_	_
8-27	1392-1402	artificial	place[81]	new[81]	_	_
8-28	1403-1417	reconstruction	place[81]	new[81]	_	_
8-29	1418-1420	of	place[81]	new[81]	_	_
8-30	1421-1431	functional	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	coref|coref	11-19[105_82]|14-5[129_83]
8-31	1432-1433	,	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-32	1434-1451	three-dimensional	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-33	1452-1453	(	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-34	1454-1456	3D	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-35	1457-1458	)	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-36	1459-1466	tissues	place[81]|object[82]|object[83]	new[81]|new[82]|new[83]	_	_
8-37	1467-1470	and	place[81]|object[83]	new[81]|new[83]	_	_
8-38	1471-1477	organs	place[81]|object[83]|object	new[81]|new[83]|giv	coref	14-8
8-39	1478-1479	.	_	_	_	_

#Text=Biomedical scaffolds are porous , implantable biomaterials , shaped to promptly restore the natural tissue anatomy and mechanical functions .
9-1	1480-1490	Biomedical	abstract[85]	giv[85]	coref	9-4[86_85]
9-2	1491-1500	scaffolds	abstract[85]	giv[85]	_	_
9-3	1501-1504	are	_	_	_	_
9-4	1505-1511	porous	abstract[86]	giv[86]	coref	10-1[90_86]
9-5	1512-1513	,	abstract[86]	giv[86]	_	_
9-6	1514-1525	implantable	abstract[86]	giv[86]	_	_
9-7	1526-1538	biomaterials	abstract[86]	giv[86]	_	_
9-8	1539-1540	,	abstract[86]	giv[86]	_	_
9-9	1541-1547	shaped	abstract[86]	giv[86]	_	_
9-10	1548-1550	to	abstract[86]	giv[86]	_	_
9-11	1551-1559	promptly	abstract[86]	giv[86]	_	_
9-12	1560-1567	restore	abstract[86]	giv[86]	_	_
9-13	1568-1571	the	abstract[86]|abstract[88]	giv[86]|new[88]	_	_
9-14	1572-1579	natural	abstract[86]|abstract[88]	giv[86]|new[88]	_	_
9-15	1580-1586	tissue	abstract[86]|object|abstract[88]	giv[86]|giv|new[88]	coref	11-26
9-16	1587-1594	anatomy	abstract[86]|abstract[88]	giv[86]|new[88]	_	_
9-17	1595-1598	and	abstract[86]	giv[86]	_	_
9-18	1599-1609	mechanical	abstract[86]|abstract[89]	giv[86]|new[89]	coref	20-23[204_89]
9-19	1610-1619	functions	abstract[86]|abstract[89]	giv[86]|new[89]	_	_
9-20	1620-1621	.	_	_	_	_

#Text=The scaffolds must also be capable of controlling foreign body reaction and new-tissue formation by targeted presentation and delivery of key molecules , e.g. , anti-inflammatory , growth factors , and proteins .
10-1	1622-1625	The	abstract[90]	giv[90]	coref	11-6[0_90]
10-2	1626-1635	scaffolds	abstract[90]	giv[90]	_	_
10-3	1636-1640	must	_	_	_	_
10-4	1641-1645	also	_	_	_	_
10-5	1646-1648	be	_	_	_	_
10-6	1649-1656	capable	_	_	_	_
10-7	1657-1659	of	_	_	_	_
10-8	1660-1671	controlling	_	_	_	_
10-9	1672-1679	foreign	object[91]|event[92]	giv[91]|new[92]	_	_
10-10	1680-1684	body	object[91]|event[92]	giv[91]|new[92]	_	_
10-11	1685-1693	reaction	event[92]	new[92]	_	_
10-12	1694-1697	and	_	_	_	_
10-13	1698-1708	new-tissue	event[93]	new[93]	_	_
10-14	1709-1718	formation	event[93]	new[93]	_	_
10-15	1719-1721	by	_	_	_	_
10-16	1722-1730	targeted	event[94]	new[94]	_	_
10-17	1731-1743	presentation	event[94]	new[94]	_	_
10-18	1744-1747	and	_	_	_	_
10-19	1748-1756	delivery	event[95]	new[95]	_	_
10-20	1757-1759	of	event[95]	new[95]	_	_
10-21	1760-1763	key	event[95]|object[96]	new[95]|giv[96]	coref	11-3[100_96]
10-22	1764-1773	molecules	event[95]|object[96]	new[95]|giv[96]	_	_
10-23	1774-1775	,	_	_	_	_
10-24	1776-1780	e.g.	_	_	_	_
10-25	1781-1782	,	_	_	_	_
10-26	1783-1800	anti-inflammatory	_	_	_	_
10-27	1801-1802	,	_	_	_	_
10-28	1803-1809	growth	abstract|abstract[98]	giv|new[98]	coref|coref	18-26[184_0]|22-11[241_98]
10-29	1810-1817	factors	abstract[98]	new[98]	_	_
10-30	1818-1819	,	_	_	_	_
10-31	1820-1823	and	_	_	_	_
10-32	1824-1832	proteins	substance	new	_	_
10-33	1833-1834	.	_	_	_	_

#Text=Indeed , these molecules help scaffolds to reduce inflammation , recruit and direct differentiation of stem cells from surrounding tissues and ultimately , promote functional tissue integration in situ .
11-1	1835-1841	Indeed	_	_	_	_
11-2	1842-1843	,	_	_	_	_
11-3	1844-1849	these	object[100]	giv[100]	coref	19-30[190_100]
11-4	1850-1859	molecules	object[100]	giv[100]	_	_
11-5	1860-1864	help	_	_	_	_
11-6	1865-1874	scaffolds	abstract	giv	coref	12-1
11-7	1875-1877	to	_	_	_	_
11-8	1878-1884	reduce	_	_	_	_
11-9	1885-1897	inflammation	abstract	new	_	_
11-10	1898-1899	,	_	_	_	_
11-11	1900-1907	recruit	_	_	_	_
11-12	1908-1911	and	_	_	_	_
11-13	1912-1918	direct	_	_	_	_
11-14	1919-1934	differentiation	abstract[103]	new[103]	_	_
11-15	1935-1937	of	abstract[103]	new[103]	_	_
11-16	1938-1942	stem	abstract[103]|place[104]	new[103]|new[104]	coref	13-6[0_104]
11-17	1943-1948	cells	abstract[103]|place[104]	new[103]|new[104]	_	_
11-18	1949-1953	from	abstract[103]|place[104]	new[103]|new[104]	_	_
11-19	1954-1965	surrounding	abstract[103]|place[104]|object[105]	new[103]|new[104]|giv[105]	coref	13-2[120_105]
11-20	1966-1973	tissues	abstract[103]|place[104]|object[105]	new[103]|new[104]|giv[105]	_	_
11-21	1974-1977	and	_	_	_	_
11-22	1978-1988	ultimately	_	_	_	_
11-23	1989-1990	,	_	_	_	_
11-24	1991-1998	promote	_	_	_	_
11-25	1999-2009	functional	event[107]	giv[107]	_	_
11-26	2010-2016	tissue	object|event[107]	giv|giv[107]	coref	13-20
11-27	2017-2028	integration	event[107]	giv[107]	_	_
11-28	2029-2031	in	_	_	_	_
11-29	2032-2036	situ	abstract	new	_	_
11-30	2037-2038	.	_	_	_	_

#Text=Scaffolds design and fabrication have evolved greatly in the past twenty years due to the large knowledge accumulated on materials design , processing and characterization of cell/scaffold interactions .
12-1	2039-2048	Scaffolds	abstract|abstract[110]	giv|new[110]	coref|coref	12-20[115_110]|14-11
12-2	2049-2055	design	abstract[110]	new[110]	_	_
12-3	2056-2059	and	_	_	_	_
12-4	2060-2071	fabrication	abstract	giv	_	_
12-5	2072-2076	have	_	_	_	_
12-6	2077-2084	evolved	_	_	_	_
12-7	2085-2092	greatly	_	_	_	_
12-8	2093-2095	in	_	_	_	_
12-9	2096-2099	the	time[112]	new[112]	_	_
12-10	2100-2104	past	time[112]	new[112]	_	_
12-11	2105-2111	twenty	time[112]	new[112]	_	_
12-12	2112-2117	years	time[112]	new[112]	_	_
12-13	2118-2121	due	_	_	_	_
12-14	2122-2124	to	_	_	_	_
12-15	2125-2128	the	abstract[113]	new[113]	_	_
12-16	2129-2134	large	abstract[113]	new[113]	_	_
12-17	2135-2144	knowledge	abstract[113]	new[113]	_	_
12-18	2145-2156	accumulated	abstract[113]	new[113]	_	_
12-19	2157-2159	on	abstract[113]	new[113]	_	_
12-20	2160-2169	materials	abstract[113]|substance|abstract[115]	new[113]|new|giv[115]	coref|coref	17-1[168_0]|21-4[0_115]
12-21	2170-2176	design	abstract[113]|abstract[115]	new[113]|giv[115]	_	_
12-22	2177-2178	,	abstract[113]	new[113]	_	_
12-23	2179-2189	processing	abstract[113]|abstract	new[113]|new	coref	22-15
12-24	2190-2193	and	abstract[113]	new[113]	_	_
12-25	2194-2210	characterization	abstract[113]|abstract[117]	new[113]|new[117]	_	_
12-26	2211-2213	of	abstract[113]|abstract[117]	new[113]|new[117]	_	_
12-27	2214-2227	cell/scaffold	abstract[113]|abstract[117]|abstract|abstract[119]	new[113]|new[117]|new|new[119]	coref	16-61
12-28	2228-2240	interactions	abstract[113]|abstract[117]|abstract[119]	new[113]|new[117]|new[119]	_	_
12-29	2241-2242	.	_	_	_	_

#Text=In the natural tissues , cells and extracellular matrix ( ECM ) organize into 3D structures from sub-cellular to tissue level .
13-1	2243-2245	In	_	_	_	_
13-2	2246-2249	the	object[120]	giv[120]	coref	14-5[128_120]
13-3	2250-2257	natural	object[120]	giv[120]	_	_
13-4	2258-2265	tissues	object[120]	giv[120]	_	_
13-5	2266-2267	,	_	_	_	_
13-6	2268-2273	cells	place|place[122]	giv|giv[122]	coref|coref	13-6[122_0]|14-29[0_122]
13-7	2274-2277	and	place[122]	giv[122]	_	_
13-8	2278-2291	extracellular	place[122]|substance[123]	giv[122]|new[123]	coref	19-35[192_123]
13-9	2292-2298	matrix	place[122]|substance[123]	giv[122]|new[123]	_	_
13-10	2299-2300	(	_	_	_	_
13-11	2301-2304	ECM	abstract	new	coref	16-40
13-12	2305-2306	)	_	_	_	_
13-13	2307-2315	organize	abstract	new	coref|none	14-17[133_0]|13-13
13-14	2316-2320	into	_	_	_	_
13-15	2321-2323	3D	abstract[125]	new[125]	_	_
13-16	2324-2334	structures	abstract[125]	new[125]	_	_
13-17	2335-2339	from	_	_	_	_
13-18	2340-2352	sub-cellular	_	_	_	_
13-19	2353-2355	to	_	_	_	_
13-20	2356-2362	tissue	object|abstract[127]	giv|new[127]	coref	14-33[137_0]
13-21	2363-2368	level	abstract[127]	new[127]	_	_
13-22	2369-2370	.	_	_	_	_

#Text=Consequently , to engineer functional tissues and organs successfully , scaffolds must capture the essence of this cells/ECM organization and must provide a porous structure able to facilitate cells distribution and guide 3D tissue regeneration .
14-1	2371-2383	Consequently	_	_	_	_
14-2	2384-2385	,	_	_	_	_
14-3	2386-2388	to	_	_	_	_
14-4	2389-2397	engineer	_	_	_	_
14-5	2398-2408	functional	object[128]|object[129]	giv[128]|giv[129]	coref	24-23[258_128]
14-6	2409-2416	tissues	object[128]|object[129]	giv[128]|giv[129]	_	_
14-7	2417-2420	and	object[129]	giv[129]	_	_
14-8	2421-2427	organs	object[129]|object	giv[129]|giv	_	_
14-9	2428-2440	successfully	_	_	_	_
14-10	2441-2442	,	_	_	_	_
14-11	2443-2452	scaffolds	abstract	giv	coref	15-1
14-12	2453-2457	must	_	_	_	_
14-13	2458-2465	capture	_	_	_	_
14-14	2466-2469	the	abstract[132]	new[132]	_	_
14-15	2470-2477	essence	abstract[132]	new[132]	_	_
14-16	2478-2480	of	abstract[132]	new[132]	_	_
14-17	2481-2485	this	abstract[132]|abstract[133]	new[132]|new[133]	coref	16-43[0_133]
14-18	2486-2495	cells/ECM	abstract[132]|abstract[133]	new[132]|new[133]	_	_
14-19	2496-2508	organization	abstract[132]|abstract[133]	new[132]|new[133]	_	_
14-20	2509-2512	and	_	_	_	_
14-21	2513-2517	must	_	_	_	_
14-22	2518-2525	provide	_	_	_	_
14-23	2526-2527	a	abstract[134]	new[134]	coref	21-29[224_134]
14-24	2528-2534	porous	abstract[134]	new[134]	_	_
14-25	2535-2544	structure	abstract[134]	new[134]	_	_
14-26	2545-2549	able	abstract[134]	new[134]	_	_
14-27	2550-2552	to	abstract[134]	new[134]	_	_
14-28	2553-2563	facilitate	abstract[134]	new[134]	_	_
14-29	2564-2569	cells	abstract[134]|place|abstract[136]	new[134]|giv|new[136]	coref	16-34
14-30	2570-2582	distribution	abstract[134]|abstract[136]	new[134]|new[136]	_	_
14-31	2583-2586	and	abstract[134]	new[134]	_	_
14-32	2587-2592	guide	abstract[134]	new[134]	_	_
14-33	2593-2595	3D	abstract[134]|object[137]|event[138]	new[134]|giv[137]|new[138]	coref	17-29[176_137]
14-34	2596-2602	tissue	abstract[134]|object[137]|event[138]	new[134]|giv[137]|new[138]	_	_
14-35	2603-2615	regeneration	abstract[134]|event[138]	new[134]|new[138]	_	_
14-36	2616-2617	.	_	_	_	_

#Text=Scaffolds
15-1	2618-2627	Scaffolds	abstract	giv	coref	19-10[186_0]

#Text=pore size and shape , pore wall morphology , porosity , surface area and pore interconnectivity , are probably the most important architectural parameters , as they have been shown to directly impact cells migration and colonization , new ECM biosynthesis and organization , oxygen and nutrients transport to cells , as well as metabolic wastes removal in the whole cell/scaffold construct .
16-1	2628-2632	pore	abstract|abstract[141]	new|new[141]	coref	16-6
16-2	2633-2637	size	abstract[141]	new[141]	_	_
16-3	2638-2641	and	_	_	_	_
16-4	2642-2647	shape	abstract	new	_	_
16-5	2648-2649	,	_	_	_	_
16-6	2650-2654	pore	abstract|abstract[145]	giv|new[145]	coref	16-15
16-7	2655-2659	wall	object|abstract[145]	new|new[145]	_	_
16-8	2660-2670	morphology	abstract[145]	new[145]	_	_
16-9	2671-2672	,	_	_	_	_
16-10	2673-2681	porosity	substance	new	_	_
16-11	2682-2683	,	_	_	_	_
16-12	2684-2691	surface	place|abstract[148]	new|new[148]	_	_
16-13	2692-2696	area	abstract[148]	new[148]	_	_
16-14	2697-2700	and	_	_	_	_
16-15	2701-2705	pore	abstract|abstract[150]	giv|new[150]	coref	16-19[151_150]
16-16	2706-2723	interconnectivity	abstract[150]	new[150]	_	_
16-17	2724-2725	,	_	_	_	_
16-18	2726-2729	are	_	_	_	_
16-19	2730-2738	probably	abstract[151]	giv[151]	ana	16-27[0_151]
16-20	2739-2742	the	abstract[151]	giv[151]	_	_
16-21	2743-2747	most	abstract[151]	giv[151]	_	_
16-22	2748-2757	important	abstract[151]	giv[151]	_	_
16-23	2758-2771	architectural	abstract[151]	giv[151]	_	_
16-24	2772-2782	parameters	abstract[151]	giv[151]	_	_
16-25	2783-2784	,	abstract[151]	giv[151]	_	_
16-26	2785-2787	as	abstract[151]	giv[151]	_	_
16-27	2788-2792	they	abstract[151]|abstract	giv[151]|giv	coref	23-10
16-28	2793-2797	have	abstract[151]	giv[151]	_	_
16-29	2798-2802	been	abstract[151]	giv[151]	_	_
16-30	2803-2808	shown	abstract[151]	giv[151]	_	_
16-31	2809-2811	to	abstract[151]	giv[151]	_	_
16-32	2812-2820	directly	abstract[151]	giv[151]	_	_
16-33	2821-2827	impact	abstract[151]	giv[151]	_	_
16-34	2828-2833	cells	abstract[151]|place|event[154]	giv[151]|giv|new[154]	coref	16-50
16-35	2834-2843	migration	abstract[151]|event[154]	giv[151]|new[154]	_	_
16-36	2844-2847	and	abstract[151]	giv[151]	_	_
16-37	2848-2860	colonization	abstract[151]|event	giv[151]|new	_	_
16-38	2861-2862	,	abstract[151]	giv[151]	_	_
16-39	2863-2866	new	abstract[151]|abstract[157]	giv[151]|new[157]	coref	20-37[209_157]
16-40	2867-2870	ECM	abstract[151]|abstract|abstract[157]	giv[151]|giv|new[157]	coref	20-40[210_0]
16-41	2871-2883	biosynthesis	abstract[151]|abstract[157]	giv[151]|new[157]	_	_
16-42	2884-2887	and	abstract[151]	giv[151]	_	_
16-43	2888-2900	organization	abstract[151]|abstract	giv[151]|giv	_	_
16-44	2901-2902	,	abstract[151]	giv[151]	_	_
16-45	2903-2909	oxygen	abstract[151]|substance|abstract[161]	giv[151]|new|new[161]	_	_
16-46	2910-2913	and	abstract[151]|abstract[161]	giv[151]|new[161]	_	_
16-47	2914-2923	nutrients	abstract[151]|substance|abstract[161]	giv[151]|new|new[161]	_	_
16-48	2924-2933	transport	abstract[151]|abstract[161]	giv[151]|new[161]	_	_
16-49	2934-2936	to	abstract[151]|abstract[161]	giv[151]|new[161]	_	_
16-50	2937-2942	cells	abstract[151]|abstract[161]|place	giv[151]|new[161]|giv	coref	19-42
16-51	2943-2944	,	abstract[151]	giv[151]	_	_
16-52	2945-2947	as	abstract[151]	giv[151]	_	_
16-53	2948-2952	well	abstract[151]	giv[151]	_	_
16-54	2953-2955	as	abstract[151]	giv[151]	_	_
16-55	2956-2965	metabolic	abstract[151]|substance[163]|event[164]	giv[151]|new[163]|new[164]	_	_
16-56	2966-2972	wastes	abstract[151]|substance[163]|event[164]	giv[151]|new[163]|new[164]	_	_
16-57	2973-2980	removal	abstract[151]|event[164]	giv[151]|new[164]	_	_
16-58	2981-2983	in	abstract[151]|event[164]	giv[151]|new[164]	_	_
16-59	2984-2987	the	abstract[151]|event[164]|abstract[166]	giv[151]|new[164]|new[166]	_	_
16-60	2988-2993	whole	abstract[151]|event[164]|abstract[166]	giv[151]|new[164]|new[166]	_	_
16-61	2994-3007	cell/scaffold	abstract[151]|event[164]|abstract|abstract[166]	giv[151]|new[164]|giv|new[166]	_	_
16-62	3008-3017	construct	abstract[151]|event[164]|abstract[166]	giv[151]|new[164]|new[166]	_	_
16-63	3018-3019	.	_	_	_	_

#Text=The scaffold material must be selected and/or designed with a degradation and resorption rate such that scaffold strength is retained until the tissue-engineered transplant is fully remodeled by the host tissue and can assume its own structural role .
17-1	3020-3023	The	substance[168]	giv[168]	_	_
17-2	3024-3032	scaffold	object|substance[168]	new|giv[168]	coref	17-17
17-3	3033-3041	material	substance[168]	giv[168]	_	_
17-4	3042-3046	must	_	_	_	_
17-5	3047-3049	be	_	_	_	_
17-6	3050-3058	selected	_	_	_	_
17-7	3059-3065	and/or	_	_	_	_
17-8	3066-3074	designed	_	_	_	_
17-9	3075-3079	with	_	_	_	_
17-10	3080-3081	a	abstract[171]	new[171]	_	_
17-11	3082-3093	degradation	abstract|abstract[171]	new|new[171]	ana	17-35
17-12	3094-3097	and	abstract[171]	new[171]	_	_
17-13	3098-3108	resorption	abstract|abstract[171]	new|new[171]	_	_
17-14	3109-3113	rate	abstract[171]	new[171]	_	_
17-15	3114-3118	such	abstract[171]	new[171]	_	_
17-16	3119-3123	that	abstract[171]	new[171]	_	_
17-17	3124-3132	scaffold	abstract[171]|object|abstract[173]	new[171]|giv|new[173]	coref	21-25
17-18	3133-3141	strength	abstract[171]|abstract[173]	new[171]|new[173]	_	_
17-19	3142-3144	is	abstract[171]	new[171]	_	_
17-20	3145-3153	retained	abstract[171]	new[171]	_	_
17-21	3154-3159	until	_	_	_	_
17-22	3160-3163	the	object[174]	new[174]	_	_
17-23	3164-3181	tissue-engineered	object[174]	new[174]	_	_
17-24	3182-3192	transplant	object[174]	new[174]	_	_
17-25	3193-3195	is	_	_	_	_
17-26	3196-3201	fully	_	_	_	_
17-27	3202-3211	remodeled	_	_	_	_
17-28	3212-3214	by	_	_	_	_
17-29	3215-3218	the	object[176]	giv[176]	coref	18-26[0_176]
17-30	3219-3223	host	person|object[176]	new|giv[176]	_	_
17-31	3224-3230	tissue	object[176]	giv[176]	_	_
17-32	3231-3234	and	_	_	_	_
17-33	3235-3238	can	_	_	_	_
17-34	3239-3245	assume	_	_	_	_
17-35	3246-3249	its	abstract|abstract[178]	giv|new[178]	_	_
17-36	3250-3253	own	abstract[178]	new[178]	_	_
17-37	3254-3264	structural	abstract[178]	new[178]	_	_
17-38	3265-3269	role	abstract[178]	new[178]	_	_
17-39	3270-3271	.	_	_	_	_

#Text=More importantly , controlling mechanical properties at cellular and sub-cellular levels is important to emulate as closely as possible the in vivo cell behavior and tissue growth .
18-1	3272-3276	More	_	_	_	_
18-2	3277-3288	importantly	_	_	_	_
18-3	3289-3290	,	_	_	_	_
18-4	3291-3302	controlling	_	_	_	_
18-5	3303-3313	mechanical	abstract[179]	new[179]	coref	19-4[185_179]
18-6	3314-3324	properties	abstract[179]	new[179]	_	_
18-7	3325-3327	at	_	_	_	_
18-8	3328-3336	cellular	abstract[180]	new[180]	_	_
18-9	3337-3340	and	abstract[180]	new[180]	_	_
18-10	3341-3353	sub-cellular	abstract[180]	new[180]	_	_
18-11	3354-3360	levels	abstract[180]	new[180]	_	_
18-12	3361-3363	is	_	_	_	_
18-13	3364-3373	important	_	_	_	_
18-14	3374-3376	to	_	_	_	_
18-15	3377-3384	emulate	_	_	_	_
18-16	3385-3387	as	_	_	_	_
18-17	3388-3395	closely	_	_	_	_
18-18	3396-3398	as	_	_	_	_
18-19	3399-3407	possible	_	_	_	_
18-20	3408-3411	the	abstract[182]	new[182]	coref	19-42[195_182]
18-21	3412-3414	in	abstract[182]	new[182]	_	_
18-22	3415-3419	vivo	abstract[182]	new[182]	_	_
18-23	3420-3424	cell	place|abstract[182]	new|new[182]	_	_
18-24	3425-3433	behavior	abstract[182]	new[182]	_	_
18-25	3434-3437	and	_	_	_	_
18-26	3438-3444	tissue	object|abstract[184]	giv|giv[184]	coref|coref	20-47|20-47[212_184]
18-27	3445-3451	growth	abstract[184]	giv[184]	_	_
18-28	3452-3453	.	_	_	_	_

#Text=Nevertheless , controlling the morphological and biomechanical properties of porous scaffolds is not enough for the success of scaffolds-based therapies , as there is also the need to load matricellular and soluble molecules inside scaffolds ’ matrix as biochemical regulators of cells behavior .
19-1	3454-3466	Nevertheless	_	_	_	_
19-2	3467-3468	,	_	_	_	_
19-3	3469-3480	controlling	_	_	_	_
19-4	3481-3484	the	abstract[185]	giv[185]	coref	24-36[261_185]
19-5	3485-3498	morphological	abstract[185]	giv[185]	_	_
19-6	3499-3502	and	abstract[185]	giv[185]	_	_
19-7	3503-3516	biomechanical	abstract[185]	giv[185]	_	_
19-8	3517-3527	properties	abstract[185]	giv[185]	_	_
19-9	3528-3530	of	abstract[185]	giv[185]	_	_
19-10	3531-3537	porous	abstract[185]|abstract[186]	giv[185]|giv[186]	coref	19-35[191_186]
19-11	3538-3547	scaffolds	abstract[185]|abstract[186]	giv[185]|giv[186]	_	_
19-12	3548-3550	is	_	_	_	_
19-13	3551-3554	not	_	_	_	_
19-14	3555-3561	enough	_	_	_	_
19-15	3562-3565	for	_	_	_	_
19-16	3566-3569	the	abstract[187]	new[187]	_	_
19-17	3570-3577	success	abstract[187]	new[187]	_	_
19-18	3578-3580	of	abstract[187]	new[187]	_	_
19-19	3581-3596	scaffolds-based	abstract[187]|abstract[188]	new[187]|new[188]	_	_
19-20	3597-3606	therapies	abstract[187]|abstract[188]	new[187]|new[188]	_	_
19-21	3607-3608	,	_	_	_	_
19-22	3609-3611	as	_	_	_	_
19-23	3612-3617	there	_	_	_	_
19-24	3618-3620	is	_	_	_	_
19-25	3621-3625	also	_	_	_	_
19-26	3626-3629	the	abstract[189]	giv[189]	_	_
19-27	3630-3634	need	abstract[189]	giv[189]	_	_
19-28	3635-3637	to	abstract[189]	giv[189]	_	_
19-29	3638-3642	load	abstract[189]	giv[189]	_	_
19-30	3643-3656	matricellular	abstract[189]|object[190]	giv[189]|giv[190]	_	_
19-31	3657-3660	and	abstract[189]|object[190]	giv[189]|giv[190]	_	_
19-32	3661-3668	soluble	abstract[189]|object[190]	giv[189]|giv[190]	_	_
19-33	3669-3678	molecules	abstract[189]|object[190]	giv[189]|giv[190]	_	_
19-34	3679-3685	inside	abstract[189]	giv[189]	_	_
19-35	3686-3695	scaffolds	abstract[189]|abstract[191]|substance[192]	giv[189]|giv[191]|giv[192]	coref	20-7[197_191]
19-36	3696-3697	’	abstract[189]|abstract[191]|substance[192]	giv[189]|giv[191]|giv[192]	_	_
19-37	3698-3704	matrix	abstract[189]|substance[192]	giv[189]|giv[192]	_	_
19-38	3705-3707	as	abstract[189]	giv[189]	_	_
19-39	3708-3719	biochemical	abstract[189]|substance[193]	giv[189]|new[193]	_	_
19-40	3720-3730	regulators	abstract[189]|substance[193]	giv[189]|new[193]	_	_
19-41	3731-3733	of	abstract[189]|substance[193]	giv[189]|new[193]	_	_
19-42	3734-3739	cells	abstract[189]|substance[193]|place|abstract[195]	giv[189]|new[193]|giv|giv[195]	ana|coref	20-3[0_195]|20-23[203_0]
19-43	3740-3748	behavior	abstract[189]|substance[193]|abstract[195]	giv[189]|new[193]|giv[195]	_	_
19-44	3749-3750	.	_	_	_	_

#Text=Indeed , it is reported that porous scaffolds releasing biochemical signals following a precise dose and time intervals to target sites stimulate cells ’ functions ( e.g. , adhesion , proliferation and migration ) , promote the biosynthesis of new ECM and , ultimately , guide tissue growth , morphogenesis and vascularization .
20-1	3751-3757	Indeed	_	_	_	_
20-2	3758-3759	,	_	_	_	_
20-3	3760-3762	it	abstract	giv	_	_
20-4	3763-3765	is	_	_	_	_
20-5	3766-3774	reported	_	_	_	_
20-6	3775-3779	that	_	_	_	_
20-7	3780-3786	porous	abstract[197]	giv[197]	coref	21-2[215_197]
20-8	3787-3796	scaffolds	abstract[197]	giv[197]	_	_
20-9	3797-3806	releasing	abstract[197]	giv[197]	_	_
20-10	3807-3818	biochemical	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
20-11	3819-3826	signals	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
20-12	3827-3836	following	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
20-13	3837-3838	a	abstract[197]|abstract[198]|abstract[199]	giv[197]|new[198]|new[199]	_	_
20-14	3839-3846	precise	abstract[197]|abstract[198]|abstract[199]	giv[197]|new[198]|new[199]	_	_
20-15	3847-3851	dose	abstract[197]|abstract[198]|abstract[199]	giv[197]|new[198]|new[199]	_	_
20-16	3852-3855	and	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
20-17	3856-3860	time	abstract[197]|abstract[198]|time|time[201]	giv[197]|new[198]|new|new[201]	_	_
20-18	3861-3870	intervals	abstract[197]|abstract[198]|time[201]	giv[197]|new[198]|new[201]	_	_
20-19	3871-3873	to	abstract[197]	giv[197]	_	_
20-20	3874-3880	target	abstract[197]|place[202]	giv[197]|new[202]	_	_
20-21	3881-3886	sites	abstract[197]|place[202]	giv[197]|new[202]	_	_
20-22	3887-3896	stimulate	_	_	_	_
20-23	3897-3902	cells	place[203]|abstract[204]	giv[203]|giv[204]	appos|coref	20-27[205_204]|21-46[228_203]
20-24	3903-3904	’	place[203]|abstract[204]	giv[203]|giv[204]	_	_
20-25	3905-3914	functions	abstract[204]	giv[204]	_	_
20-26	3915-3916	(	_	_	_	_
20-27	3917-3921	e.g.	abstract[205]|abstract[206]	giv[205]|giv[206]	appos|appos	20-27[206_205]|20-31[0_206]
20-28	3922-3923	,	abstract[205]|abstract[206]	giv[205]|giv[206]	_	_
20-29	3924-3932	adhesion	abstract[205]|abstract[206]	giv[205]|giv[206]	_	_
20-30	3933-3934	,	abstract[206]	giv[206]	_	_
20-31	3935-3948	proliferation	abstract[206]|abstract	giv[206]|giv	appos	20-33
20-32	3949-3952	and	abstract[206]	giv[206]	_	_
20-33	3953-3962	migration	abstract[206]|abstract	giv[206]|giv	_	_
20-34	3963-3964	)	_	_	_	_
20-35	3965-3966	,	_	_	_	_
20-36	3967-3974	promote	_	_	_	_
20-37	3975-3978	the	abstract[209]	giv[209]	_	_
20-38	3979-3991	biosynthesis	abstract[209]	giv[209]	_	_
20-39	3992-3994	of	abstract[209]	giv[209]	_	_
20-40	3995-3998	new	abstract[209]|abstract[210]	giv[209]|giv[210]	coref	21-30[0_210]
20-41	3999-4002	ECM	abstract[209]|abstract[210]	giv[209]|giv[210]	_	_
20-42	4003-4006	and	_	_	_	_
20-43	4007-4008	,	_	_	_	_
20-44	4009-4019	ultimately	_	_	_	_
20-45	4020-4021	,	_	_	_	_
20-46	4022-4027	guide	_	_	_	_
20-47	4028-4034	tissue	object|abstract[212]	giv|giv[212]	coref|coref	21-46[229_212]|21-50
20-48	4035-4041	growth	abstract[212]	giv[212]	_	_
20-49	4042-4043	,	_	_	_	_
20-50	4044-4057	morphogenesis	abstract	new	coref	21-50[231_0]
20-51	4058-4061	and	_	_	_	_
20-52	4062-4077	vascularization	abstract	new	_	_
20-53	4078-4079	.	_	_	_	_

#Text=Increasing scaffolds ’ design complexity is therefore extremely demanding and scientists face some important challenges , such as : ( 1 ) engineering of scaffold microarchitecture to mimic the ECM structure , ( 2 ) imprinting topological and biochemical patterns inside scaffolds pores to guide cells ’ growth and tissue morphogenesis , and ( 3 ) developing automated processes for the precise and reliable control of scaffolds ’ features and geometry .
21-1	4080-4090	Increasing	_	_	_	_
21-2	4091-4100	scaffolds	abstract[215]|abstract[217]	giv[215]|new[217]	coref	21-42[0_215]
21-3	4101-4102	’	abstract[215]|abstract[217]	giv[215]|new[217]	_	_
21-4	4103-4109	design	abstract|abstract[217]	giv|new[217]	_	_
21-5	4110-4120	complexity	abstract[217]	new[217]	_	_
21-6	4121-4123	is	_	_	_	_
21-7	4124-4133	therefore	_	_	_	_
21-8	4134-4143	extremely	_	_	_	_
21-9	4144-4153	demanding	_	_	_	_
21-10	4154-4157	and	_	_	_	_
21-11	4158-4168	scientists	person	new	_	_
21-12	4169-4173	face	_	_	_	_
21-13	4174-4178	some	abstract[219]	new[219]	_	_
21-14	4179-4188	important	abstract[219]	new[219]	_	_
21-15	4189-4199	challenges	abstract[219]	new[219]	_	_
21-16	4200-4201	,	abstract[219]	new[219]	_	_
21-17	4202-4206	such	abstract[219]	new[219]	_	_
21-18	4207-4209	as	abstract[219]	new[219]	_	_
21-19	4210-4211	:	abstract[219]	new[219]	_	_
21-20	4212-4213	(	abstract[219]	new[219]	_	_
21-21	4214-4215	1	abstract[219]	new[219]	_	_
21-22	4216-4217	)	abstract[219]	new[219]	_	_
21-23	4218-4229	engineering	abstract[219]|abstract[220]	new[219]|giv[220]	_	_
21-24	4230-4232	of	abstract[219]|abstract[220]	new[219]|giv[220]	_	_
21-25	4233-4241	scaffold	abstract[219]|abstract[220]|object|abstract[222]	new[219]|giv[220]|giv|new[222]	_	_
21-26	4242-4259	microarchitecture	abstract[219]|abstract[220]|abstract[222]	new[219]|giv[220]|new[222]	_	_
21-27	4260-4262	to	abstract[219]	new[219]	_	_
21-28	4263-4268	mimic	abstract[219]	new[219]	_	_
21-29	4269-4272	the	abstract[219]|abstract[224]	new[219]|giv[224]	_	_
21-30	4273-4276	ECM	abstract[219]|abstract|abstract[224]	new[219]|giv|giv[224]	coref	24-18[257_0]
21-31	4277-4286	structure	abstract[219]|abstract[224]	new[219]|giv[224]	_	_
21-32	4287-4288	,	abstract[219]	new[219]	_	_
21-33	4289-4290	(	abstract[219]	new[219]	_	_
21-34	4291-4292	2	abstract[219]	new[219]	_	_
21-35	4293-4294	)	abstract[219]	new[219]	_	_
21-36	4295-4305	imprinting	abstract[219]	new[219]	_	_
21-37	4306-4317	topological	abstract[219]|abstract[225]	new[219]|new[225]	_	_
21-38	4318-4321	and	abstract[219]|abstract[225]	new[219]|new[225]	_	_
21-39	4322-4333	biochemical	abstract[219]|abstract[225]	new[219]|new[225]	_	_
21-40	4334-4342	patterns	abstract[219]|abstract[225]	new[219]|new[225]	_	_
21-41	4343-4349	inside	abstract[219]|abstract[225]	new[219]|new[225]	_	_
21-42	4350-4359	scaffolds	abstract[219]|abstract[225]|abstract|object[227]	new[219]|new[225]|giv|new[227]	coref	21-67[234_0]
21-43	4360-4365	pores	abstract[219]|abstract[225]|object[227]	new[219]|new[225]|new[227]	_	_
21-44	4366-4368	to	abstract[219]	new[219]	_	_
21-45	4369-4374	guide	abstract[219]	new[219]	_	_
21-46	4375-4380	cells	abstract[219]|place[228]|abstract[229]	new[219]|giv[228]|giv[229]	coref	22-11[0_229]
21-47	4381-4382	’	abstract[219]|place[228]|abstract[229]	new[219]|giv[228]|giv[229]	_	_
21-48	4383-4389	growth	abstract[219]|abstract[229]	new[219]|giv[229]	_	_
21-49	4390-4393	and	abstract[219]	new[219]	_	_
21-50	4394-4400	tissue	abstract[219]|object|abstract[231]	new[219]|giv|giv[231]	_	_
21-51	4401-4414	morphogenesis	abstract[219]|abstract[231]	new[219]|giv[231]	_	_
21-52	4415-4416	,	abstract[219]	new[219]	_	_
21-53	4417-4420	and	abstract[219]	new[219]	_	_
21-54	4421-4422	(	abstract[219]	new[219]	_	_
21-55	4423-4424	3	abstract[219]	new[219]	_	_
21-56	4425-4426	)	abstract[219]	new[219]	_	_
21-57	4427-4437	developing	abstract[219]	new[219]	_	_
21-58	4438-4447	automated	abstract[219]|abstract[232]	new[219]|new[232]	_	_
21-59	4448-4457	processes	abstract[219]|abstract[232]	new[219]|new[232]	_	_
21-60	4458-4461	for	abstract[219]|abstract[232]	new[219]|new[232]	_	_
21-61	4462-4465	the	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-62	4466-4473	precise	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-63	4474-4477	and	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-64	4478-4486	reliable	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-65	4487-4494	control	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-66	4495-4497	of	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-67	4498-4507	scaffolds	abstract[219]|abstract[232]|abstract[233]|abstract[234]|abstract[235]	new[219]|new[232]|new[233]|giv[234]|new[235]	coref	22-1[237_234]
21-68	4508-4509	’	abstract[219]|abstract[232]|abstract[233]|abstract[234]|abstract[235]	new[219]|new[232]|new[233]|giv[234]|new[235]	_	_
21-69	4510-4518	features	abstract[219]|abstract[232]|abstract[233]|abstract[235]	new[219]|new[232]|new[233]|new[235]	_	_
21-70	4519-4522	and	abstract[219]|abstract[232]|abstract[233]	new[219]|new[232]|new[233]	_	_
21-71	4523-4531	geometry	abstract[219]|abstract[232]|abstract[233]|abstract	new[219]|new[232]|new[233]|new	_	_
21-72	4532-4533	.	_	_	_	_

#Text=Porous bioactive scaffolds can be fabricated by combining biomaterials and growth factors through different processing techniques .
22-1	4534-4540	Porous	abstract[237]	giv[237]	coref	22-9[0_237]
22-2	4541-4550	bioactive	abstract[237]	giv[237]	_	_
22-3	4551-4560	scaffolds	abstract[237]	giv[237]	_	_
22-4	4561-4564	can	_	_	_	_
22-5	4565-4567	be	_	_	_	_
22-6	4568-4578	fabricated	_	_	_	_
22-7	4579-4581	by	_	_	_	_
22-8	4582-4591	combining	_	_	_	_
22-9	4592-4604	biomaterials	abstract|abstract[239]	giv|giv[239]	coref|coref	22-9[239_0]|24-9[255_239]
22-10	4605-4608	and	abstract[239]	giv[239]	_	_
22-11	4609-4615	growth	abstract[239]|abstract|abstract[241]	giv[239]|giv|giv[241]	_	_
22-12	4616-4623	factors	abstract[239]|abstract[241]	giv[239]|giv[241]	_	_
22-13	4624-4631	through	_	_	_	_
22-14	4632-4641	different	abstract[243]	new[243]	_	_
22-15	4642-4652	processing	abstract|abstract[243]	giv|new[243]	_	_
22-16	4653-4663	techniques	abstract[243]	new[243]	_	_
22-17	4664-4665	.	_	_	_	_

#Text=This review focuses the attention on modular approaches where samples are built by the “ bottom-up ” assembly of smaller units or “ modules ” , each one specifically designed for distinct tasks .
23-1	4666-4670	This	abstract[244]	new[244]	_	_
23-2	4671-4677	review	abstract[244]	new[244]	_	_
23-3	4678-4685	focuses	_	_	_	_
23-4	4686-4689	the	abstract[245]	new[245]	_	_
23-5	4690-4699	attention	abstract[245]	new[245]	_	_
23-6	4700-4702	on	_	_	_	_
23-7	4703-4710	modular	abstract[246]	new[246]	coref	24-1[253_246]
23-8	4711-4721	approaches	abstract[246]	new[246]	_	_
23-9	4722-4727	where	abstract[246]	new[246]	_	_
23-10	4728-4735	samples	abstract[246]|abstract	new[246]|giv	_	_
23-11	4736-4739	are	abstract[246]	new[246]	_	_
23-12	4740-4745	built	abstract[246]	new[246]	_	_
23-13	4746-4748	by	abstract[246]	new[246]	_	_
23-14	4749-4752	the	abstract[246]|event[248]	new[246]|new[248]	_	_
23-15	4753-4754	“	abstract[246]|event[248]	new[246]|new[248]	_	_
23-16	4755-4764	bottom-up	abstract[246]|event[248]	new[246]|new[248]	_	_
23-17	4765-4766	”	abstract[246]|event[248]	new[246]|new[248]	_	_
23-18	4767-4775	assembly	abstract[246]|event[248]	new[246]|new[248]	_	_
23-19	4776-4778	of	abstract[246]|event[248]	new[246]|new[248]	_	_
23-20	4779-4786	smaller	abstract[246]|event[248]|object[249]	new[246]|new[248]|new[249]	_	_
23-21	4787-4792	units	abstract[246]|event[248]|object[249]	new[246]|new[248]|new[249]	_	_
23-22	4793-4795	or	abstract[246]|event[248]	new[246]|new[248]	_	_
23-23	4796-4797	“	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	coref	24-31[260_250]
23-24	4798-4805	modules	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-25	4806-4807	”	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-26	4808-4809	,	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-27	4810-4814	each	abstract[246]|event[248]|object[250]|abstract[251]	new[246]|new[248]|new[250]|new[251]	_	_
23-28	4815-4818	one	abstract[246]|event[248]|object[250]|abstract[251]	new[246]|new[248]|new[250]|new[251]	_	_
23-29	4819-4831	specifically	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-30	4832-4840	designed	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-31	4841-4844	for	abstract[246]|event[248]|object[250]	new[246]|new[248]|new[250]	_	_
23-32	4845-4853	distinct	abstract[246]|event[248]|object[250]|abstract[252]	new[246]|new[248]|new[250]|new[252]	_	_
23-33	4854-4859	tasks	abstract[246]|event[248]|object[250]|abstract[252]	new[246]|new[248]|new[250]|new[252]	_	_
23-34	4860-4861	.	_	_	_	_

#Text=Bottom up approaches have the potential to build scaffolds mimicking the complex molecular and structural microenvironment of the native ECM of every kind of tissues by the proper assembly of micro- and nano-structured modules with well-defined morphological and biochemical properties .
24-1	4862-4868	Bottom	abstract[253]	giv[253]	_	_
24-2	4869-4871	up	abstract[253]	giv[253]	_	_
24-3	4872-4882	approaches	abstract[253]	giv[253]	_	_
24-4	4883-4887	have	_	_	_	_
24-5	4888-4891	the	abstract[254]	new[254]	_	_
24-6	4892-4901	potential	abstract[254]	new[254]	_	_
24-7	4902-4904	to	abstract[254]	new[254]	_	_
24-8	4905-4910	build	abstract[254]	new[254]	_	_
24-9	4911-4920	scaffolds	abstract[254]|abstract[255]	new[254]|giv[255]	_	_
24-10	4921-4930	mimicking	abstract[254]|abstract[255]	new[254]|giv[255]	_	_
24-11	4931-4934	the	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-12	4935-4942	complex	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-13	4943-4952	molecular	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-14	4953-4956	and	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-15	4957-4967	structural	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-16	4968-4984	microenvironment	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-17	4985-4987	of	abstract[254]|abstract[255]|abstract[256]	new[254]|giv[255]|new[256]	_	_
24-18	4988-4991	the	abstract[254]|abstract[255]|abstract[256]|abstract[257]	new[254]|giv[255]|new[256]|giv[257]	_	_
24-19	4992-4998	native	abstract[254]|abstract[255]|abstract[256]|abstract[257]	new[254]|giv[255]|new[256]|giv[257]	_	_
24-20	4999-5002	ECM	abstract[254]|abstract[255]|abstract[256]|abstract[257]	new[254]|giv[255]|new[256]|giv[257]	_	_
24-21	5003-5005	of	abstract[254]|abstract[255]|abstract[256]|abstract[257]	new[254]|giv[255]|new[256]|giv[257]	_	_
24-22	5006-5011	every	abstract[254]|abstract[255]|abstract[256]|abstract[257]	new[254]|giv[255]|new[256]|giv[257]	_	_
24-23	5012-5016	kind	abstract[254]|abstract[255]|abstract[256]|abstract[257]|object[258]	new[254]|giv[255]|new[256]|giv[257]|giv[258]	_	_
24-24	5017-5019	of	abstract[254]|abstract[255]|abstract[256]|abstract[257]|object[258]	new[254]|giv[255]|new[256]|giv[257]|giv[258]	_	_
24-25	5020-5027	tissues	abstract[254]|abstract[255]|abstract[256]|abstract[257]|object[258]	new[254]|giv[255]|new[256]|giv[257]|giv[258]	_	_
24-26	5028-5030	by	abstract[254]|abstract[255]	new[254]|giv[255]	_	_
24-27	5031-5034	the	abstract[254]|abstract[255]|event[259]	new[254]|giv[255]|new[259]	_	_
24-28	5035-5041	proper	abstract[254]|abstract[255]|event[259]	new[254]|giv[255]|new[259]	_	_
24-29	5042-5050	assembly	abstract[254]|abstract[255]|event[259]	new[254]|giv[255]|new[259]	_	_
24-30	5051-5053	of	abstract[254]|abstract[255]|event[259]	new[254]|giv[255]|new[259]	_	_
24-31	5054-5060	micro-	abstract[254]|abstract[255]|event[259]|object[260]	new[254]|giv[255]|new[259]|giv[260]	_	_
24-32	5061-5064	and	abstract[254]|abstract[255]|event[259]|object[260]	new[254]|giv[255]|new[259]|giv[260]	_	_
24-33	5065-5080	nano-structured	abstract[254]|abstract[255]|event[259]|object[260]	new[254]|giv[255]|new[259]|giv[260]	_	_
24-34	5081-5088	modules	abstract[254]|abstract[255]|event[259]|object[260]	new[254]|giv[255]|new[259]|giv[260]	_	_
24-35	5089-5093	with	abstract[254]|abstract[255]|event[259]|object[260]	new[254]|giv[255]|new[259]|giv[260]	_	_
24-36	5094-5106	well-defined	abstract[254]|abstract[255]|event[259]|object[260]|abstract[261]	new[254]|giv[255]|new[259]|giv[260]|giv[261]	_	_
24-37	5107-5120	morphological	abstract[254]|abstract[255]|event[259]|object[260]|abstract[261]	new[254]|giv[255]|new[259]|giv[260]|giv[261]	_	_
24-38	5121-5124	and	abstract[254]|abstract[255]|event[259]|object[260]|abstract[261]	new[254]|giv[255]|new[259]|giv[260]|giv[261]	_	_
24-39	5125-5136	biochemical	abstract[254]|abstract[255]|event[259]|object[260]|abstract[261]	new[254]|giv[255]|new[259]|giv[260]|giv[261]	_	_
24-40	5137-5147	properties	abstract[254]|abstract[255]|event[259]|object[260]|abstract[261]	new[254]|giv[255]|new[259]|giv[260]|giv[261]	_	_
24-41	5148-5149	.	_	_	_	_
